BioAdvance Capital is a venture capital firm. Based in Conshohocken, Pennsylvania, United States. The known portfolio counts 8 companies, including Palvella Therapeutics, Halo Labs, KayoThera, Tolerance Bio, Vittoria Biotherapeutics and Senzo.
Is BioAdvance Capital a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- HardwareHealthcare
Who to pitch at BioAdvance Capital
BioAdvance Capital portfolio companies (8)
- Palvella Therapeutics
- Halo Labs
- KayoThera
- Tolerance Bio
- Vittoria Biotherapeutics
- Senzo
- Innervace
- Overwatch Health
Co-investors
Funds that share portfolio companies with BioAdvance Capital.
Similar funds
Showing 20 of 100
About BioAdvance Capital
The firm's listing covers sectors Hardware and Healthcare, and focus areas Bioprinting, Biotech, Diagnostics and Digital Health; known deals cluster at Growth, Late-Stage and Seed.
Of the 4 people on file at BioAdvance Capital, Shahram Hejazi (Managing Director & CEO) and Marnie McCoy (Program Director) are listed as the contacts to approach first.
BioAdvance Capital shares portfolio companies with 20 other investment firms, among them The Leukemia & Lymphoma Society’s Therapy Acceleration Program, Pier 70 Ventures and Agilent Technologies.
Frequently asked questions
What is BioAdvance Capital?
BioAdvance Capital is a venture capital firm based in Conshohocken, Pennsylvania, United States, with a known portfolio of 8 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does BioAdvance Capital invest in?
Listed sectors include Hardware and Healthcare; listed focus areas include Bioprinting, Biotech, Diagnostics and Digital Health. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does BioAdvance Capital invest at?
The known deals of BioAdvance Capital include Growth, Late-Stage and Seed rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
Who should I pitch at BioAdvance Capital?
2 of the 4 people on file at BioAdvance Capital are listed as contacts for the firm. All 4 have their own profile page.
How do I contact BioAdvance Capital?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 4 people attached to the firm have their own pages, each showing whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal